메뉴 건너뛰기
Retinal Cases and Brief Reports
Volumn 6, Issue 4, 2012, Pages 423-426
Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of vogt-koyanagi-harada syndrome
Author keywords

Cytotoxic T lymphocyte associated antigen 4 blocker; Ipilimumab; Melanoma; Uveitis; Vogt Koyanagi Harada syndrome
Indexed keywords

EID: 84871201535     PISSN: 19351089     EISSN: 19371578     Source Type: Journal    
DOI: 10.1097/ICB.0b013e31824f7130     Document Type: Article
Times cited : (74)
References (10)
  • 1
    • 0001559582 scopus 로고
    • Syndrome de Vogt-Koyanagi (Uveite Bilaterale Poliosis Alopecie Vitiligo et Dysacousie)
    • Babel J. Syndrome de Vogt-Koyanagi (Uveite bilaterale, poliosis, alopecie, vitiligo et dysacousie). Schweiz Med Wochenschr 1932;44:1136-1140.
    • (1932) Schweiz Med Wochenschr , vol.44 , pp. 1136-1140
    • Babel, J.1
  • 2
    • 0035025345 scopus 로고    scopus 로고
    • Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature
    • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131:647-652.
    • (2001) Am J Ophthalmol , vol.131 , pp. 647-652
    • Read, R.W.1    Holland, G.N.2    Rao, N.A.3
  • 3
    • 0029919345 scopus 로고    scopus 로고
    • Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
    • Sugita S, Sagawa K, Mochizuki M, et al. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol 1996;8:799-803.
    • (1996) Int Immunol , vol.8 , pp. 799-803
    • Sugita, S.1    Sagawa, K.2    Mochizuki, M.3
  • 4
    • 0029803602 scopus 로고    scopus 로고
    • Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease
    • Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Oph-thalmol 1996;80:1002-1008.
    • (1996) Br J Oph-thalmol , vol.80 , pp. 1002-1008
    • Norose, K.1    Yano, A.2
  • 6
    • 20244366111 scopus 로고    scopus 로고
    • Adoptive cell transfer therapy following non-myeloablative but lymphodeplet-ing chemotherapy for the treatment of patients with refractory metastatic melanoma
    • Dudley ME, Wunderlich JR, Yang JC, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodeplet-ing chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005;23:2346-2357.
    • (2005) J Clin Oncol , vol.23 , pp. 2346-2357
    • Dudley, M.E.1    Wunderlich, J.R.2    Yang, J.C.3
  • 7
    • 65349112495 scopus 로고    scopus 로고
    • Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma
    • Yeh S, Karne NK, Kerkar SP, et al. Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology 2009;116:981-989. e1.
    • (2009) Ophthalmology , vol.116
    • Yeh, S.1    Karne, N.K.2    Kerkar, S.P.3
  • 8
    • 7444262481 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: A new cause of uveitis
    • Robinson MR, Chan CC, Yang JC, et al. Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis. J Immunother 2004;27:478-479.
    • (2004) J Immunother , vol.27 , pp. 478-479
    • Robinson, M.R.1    Chan, C.C.2    Yang, J.C.3
  • 9
    • 27844458057 scopus 로고    scopus 로고
    • Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: A phase I/II study
    • Maker AV, Phan GQ, Attia P, et al. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol 2005;12:1005-1016.
    • (2005) Ann Surg Oncol , vol.12 , pp. 1005-1016
    • Maker, A.V.1    Phan, G.Q.2    Attia, P.3
  • 10
    • 36248987929 scopus 로고    scopus 로고
    • The role of the CTLA4 blockade in the treatment of malignant melanoma
    • Review
    • Cranmer LD, Hersh E. The role of the CTLA4 blockade in the treatment of malignant melanoma. Cancer Invest 2007;25:613-631. Review.
    • (2007) Cancer Invest , vol.25 , pp. 613-631
    • Cranmer, L.D.1    Hersh, E.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.